Effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in patients with COPD, asthma, diabetes mellitus type 2 and heart failure: protocol for a pragmatic clustered quasi-experimental study

Introduction The number of people that have one or multiple condition(s) with a chronic course is rising, which consequently challenges healthcare systems. Healthcare geared to long-term care should focus on patient-centredness, shared decision making and self-management. The Assessment of Burden of...

Full description

Saved in:
Bibliographic Details
Main Authors: Bjorn Winkens, Esther A. Boudewijns, Danny Claessens, Manuela Joore, Lotte C.E.M. Keijsers, Onno C.P. van Schayck, Annerika H.M. Gidding-Slok
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/11/e037693.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850159354365345792
author Bjorn Winkens
Esther A. Boudewijns
Danny Claessens
Manuela Joore
Lotte C.E.M. Keijsers
Onno C.P. van Schayck
Annerika H.M. Gidding-Slok
author_facet Bjorn Winkens
Esther A. Boudewijns
Danny Claessens
Manuela Joore
Lotte C.E.M. Keijsers
Onno C.P. van Schayck
Annerika H.M. Gidding-Slok
author_sort Bjorn Winkens
collection DOAJ
description Introduction The number of people that have one or multiple condition(s) with a chronic course is rising, which consequently challenges healthcare systems. Healthcare geared to long-term care should focus on patient-centredness, shared decision making and self-management. The Assessment of Burden of Chronic Conditions (ABCC) tool was developed to integrate these elements in daily healthcare practice. The ABCC tool assesses and visualises burden of disease(s), helps to make shared decisions and stimulates self-management. The present paper documents a protocol for a quasi-experimental study investigating the effectiveness and cost-effectiveness of the ABCC tool for people with chronic obstructive pulmonary disease, asthma, type 2 diabetes mellitus and/or heart failure.Methods and analysis The study has a pragmatic clustered quasi-experimental design and will be conducted in the Netherlands. The intervention will be allocated at the level of general practice. The intervention group (18 general practices, 180 patients) will use the ABCC tool during regular consultations; the control group (18 general practices, 180 patients) will maintain usual care. Outcomes include change in quality of care (Patient Assessment of Chronic Illness Care), quality of life (EuroQol-5D-5L), capability well-being (ICEpop CAPability measure for Adults), patients’ activation (Patient Activation Measure) and costs. Follow-up time will be 18 months. Outcomes will be analysed using linear mixed models.Ethics and dissemination Ethical approval was obtained from the Medical Ethics Committee Zuyderland-Zuyd Heerlen, the Netherlands (METCZ20180131). Results will be published in peer-reviewed journals and will be presented at national and international conferences.Trial registration number ClinicalTrials.gov Registry (NCT04127383).
format Article
id doaj-art-2823709819ec4ab5aa89b1c0d995ccfc
institution OA Journals
issn 2044-6055
language English
publishDate 2020-11-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-2823709819ec4ab5aa89b1c0d995ccfc2025-08-20T02:23:35ZengBMJ Publishing GroupBMJ Open2044-60552020-11-01101110.1136/bmjopen-2020-037693Effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in patients with COPD, asthma, diabetes mellitus type 2 and heart failure: protocol for a pragmatic clustered quasi-experimental studyBjorn Winkens0Esther A. Boudewijns1Danny Claessens2Manuela Joore3Lotte C.E.M. Keijsers4Onno C.P. van Schayck5Annerika H.M. Gidding-Slok64 Department of Methodology and Statistics, Maastricht University, Maastricht, The NetherlandsDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The NetherlandsDepartment of Family Medicine, CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, The NetherlandsClinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht UMC+, Maastricht, The NetherlandsDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The NetherlandsDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The NetherlandsDepartment of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The NetherlandsIntroduction The number of people that have one or multiple condition(s) with a chronic course is rising, which consequently challenges healthcare systems. Healthcare geared to long-term care should focus on patient-centredness, shared decision making and self-management. The Assessment of Burden of Chronic Conditions (ABCC) tool was developed to integrate these elements in daily healthcare practice. The ABCC tool assesses and visualises burden of disease(s), helps to make shared decisions and stimulates self-management. The present paper documents a protocol for a quasi-experimental study investigating the effectiveness and cost-effectiveness of the ABCC tool for people with chronic obstructive pulmonary disease, asthma, type 2 diabetes mellitus and/or heart failure.Methods and analysis The study has a pragmatic clustered quasi-experimental design and will be conducted in the Netherlands. The intervention will be allocated at the level of general practice. The intervention group (18 general practices, 180 patients) will use the ABCC tool during regular consultations; the control group (18 general practices, 180 patients) will maintain usual care. Outcomes include change in quality of care (Patient Assessment of Chronic Illness Care), quality of life (EuroQol-5D-5L), capability well-being (ICEpop CAPability measure for Adults), patients’ activation (Patient Activation Measure) and costs. Follow-up time will be 18 months. Outcomes will be analysed using linear mixed models.Ethics and dissemination Ethical approval was obtained from the Medical Ethics Committee Zuyderland-Zuyd Heerlen, the Netherlands (METCZ20180131). Results will be published in peer-reviewed journals and will be presented at national and international conferences.Trial registration number ClinicalTrials.gov Registry (NCT04127383).https://bmjopen.bmj.com/content/10/11/e037693.full
spellingShingle Bjorn Winkens
Esther A. Boudewijns
Danny Claessens
Manuela Joore
Lotte C.E.M. Keijsers
Onno C.P. van Schayck
Annerika H.M. Gidding-Slok
Effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in patients with COPD, asthma, diabetes mellitus type 2 and heart failure: protocol for a pragmatic clustered quasi-experimental study
BMJ Open
title Effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in patients with COPD, asthma, diabetes mellitus type 2 and heart failure: protocol for a pragmatic clustered quasi-experimental study
title_full Effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in patients with COPD, asthma, diabetes mellitus type 2 and heart failure: protocol for a pragmatic clustered quasi-experimental study
title_fullStr Effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in patients with COPD, asthma, diabetes mellitus type 2 and heart failure: protocol for a pragmatic clustered quasi-experimental study
title_full_unstemmed Effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in patients with COPD, asthma, diabetes mellitus type 2 and heart failure: protocol for a pragmatic clustered quasi-experimental study
title_short Effectiveness and cost-effectiveness of the Assessment of Burden of Chronic Conditions (ABCC) tool in patients with COPD, asthma, diabetes mellitus type 2 and heart failure: protocol for a pragmatic clustered quasi-experimental study
title_sort effectiveness and cost effectiveness of the assessment of burden of chronic conditions abcc tool in patients with copd asthma diabetes mellitus type 2 and heart failure protocol for a pragmatic clustered quasi experimental study
url https://bmjopen.bmj.com/content/10/11/e037693.full
work_keys_str_mv AT bjornwinkens effectivenessandcosteffectivenessoftheassessmentofburdenofchronicconditionsabcctoolinpatientswithcopdasthmadiabetesmellitustype2andheartfailureprotocolforapragmaticclusteredquasiexperimentalstudy
AT estheraboudewijns effectivenessandcosteffectivenessoftheassessmentofburdenofchronicconditionsabcctoolinpatientswithcopdasthmadiabetesmellitustype2andheartfailureprotocolforapragmaticclusteredquasiexperimentalstudy
AT dannyclaessens effectivenessandcosteffectivenessoftheassessmentofburdenofchronicconditionsabcctoolinpatientswithcopdasthmadiabetesmellitustype2andheartfailureprotocolforapragmaticclusteredquasiexperimentalstudy
AT manuelajoore effectivenessandcosteffectivenessoftheassessmentofburdenofchronicconditionsabcctoolinpatientswithcopdasthmadiabetesmellitustype2andheartfailureprotocolforapragmaticclusteredquasiexperimentalstudy
AT lottecemkeijsers effectivenessandcosteffectivenessoftheassessmentofburdenofchronicconditionsabcctoolinpatientswithcopdasthmadiabetesmellitustype2andheartfailureprotocolforapragmaticclusteredquasiexperimentalstudy
AT onnocpvanschayck effectivenessandcosteffectivenessoftheassessmentofburdenofchronicconditionsabcctoolinpatientswithcopdasthmadiabetesmellitustype2andheartfailureprotocolforapragmaticclusteredquasiexperimentalstudy
AT annerikahmgiddingslok effectivenessandcosteffectivenessoftheassessmentofburdenofchronicconditionsabcctoolinpatientswithcopdasthmadiabetesmellitustype2andheartfailureprotocolforapragmaticclusteredquasiexperimentalstudy